• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 54-68 of 131 results

1019 Exhibit: Ex 1019 US Application No 11520,479, Final Office Action dated Dec ...

Document IPR2017-01100, No. 1019-18 Exhibit - Ex 1019 US Application No 11520,479, Final Office Action dated Dec 29, 2010 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1032 Exhibit: Ex 1032 FDA Nanotechnology Task Force, Public Meeting on Nanote...

Document IPR2017-01100, No. 1032-31 Exhibit - Ex 1032 FDA Nanotechnology Task Force, Public Meeting on Nanotechnology Materials in FDA Regulated Products Oct 10, 2006 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1012 Exhibit: Ex 1012 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Sixth Day of ...

Document IPR2017-01100, No. 1012-11 Exhibit - Ex 1012 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Sixth Day of Trial, No 06 438 GMS, Dkt 624 D Del June 9, 2008 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1021 Exhibit: Ex 1021 US Application No 11520,479, Declaration of Neil P Desai Pu...

Document IPR2017-01100, No. 1021-20 Exhibit - Ex 1021 US Application No 11520,479, Declaration of Neil P Desai Pursuant to 37 CFR 1132 dated Jan 27, 2012 First Inventors Declaration (P.T.A.B. Apr....

cite Cite Document
Analyze

1028 Exhibit: Ex 1028 Liversidge et al, US Patent No 5,145,684

Document IPR2017-01100, No. 1028-27 Exhibit - Ex 1028 Liversidge et al, US Patent No 5,145,684 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1031 Exhibit: Ex 1031 Grinstaff et al, WO 9418954, Methods for In Vivo Delivery of ...

Document IPR2017-01100, No. 1031-30 Exhibit - Ex 1031 Grinstaff et al, WO 9418954, Methods for In Vivo Delivery of Biologics and Compositions Therefor published Sept 1994 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1022 Exhibit: Ex 1022 US Application No 11520,479, Non Final Office Action dated...

Document IPR2017-01100, No. 1022-21 Exhibit - Ex 1022 US Application No 11520,479, Non Final Office Action dated May 2, 2013 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1030 Exhibit: Ex 1030 FDA, Approved Drug Products with Therapeutic Equivalence...

Document IPR2017-01100, No. 1030-29 Exhibit - Ex 1030 FDA, Approved Drug Products with Therapeutic Equivalence Evaluations 33d ed 2013 Orange Book (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1025 Exhibit: Ex 1025 US Application No 11520,479, Notice of Allowance and Fees...

Document IPR2017-01100, No. 1025-24 Exhibit - Ex 1025 US Application No 11520,479, Notice of Allowance and Fees Due mailed Feb 13, 2014 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1011 Exhibit: Ex 1011 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Judgment an...

Document IPR2017-01100, No. 1011-10 Exhibit - Ex 1011 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Judgment and Verdict Form, No 06 438 GMS, Dkt 614 D Del June 16, 2008 (P.T.A.B. Apr. 4, 2017...

cite Cite Document
Analyze

1016 Exhibit: Ex 1016 Administrative Documents, New Drug Application No 21 660

Document IPR2017-01100, No. 1016-15 Exhibit - Ex 1016 Administrative Documents, New Drug Application No 21 660 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1020 Exhibit: Ex 1020 US Application No 11520,479, Amendment After Final Action...

Document IPR2017-01100, No. 1020-19 Exhibit - Ex 1020 US Application No 11520,479, Amendment After Final Action Under 37 CFR 1114 dated Jan 27, 2012 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1006 Exhibit: Ex 1006 Remingtons Pharmaceutical Sciences 18th ed 1990

Document IPR2017-01100, No. 1006-5 Exhibit - Ex 1006 Remingtons Pharmaceutical Sciences 18th ed 1990 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1013 Exhibit: Ex 1013 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Seventh Day...

Document IPR2017-01100, No. 1013-12 Exhibit - Ex 1013 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Seventh Day of Trial, No 06 438 GMS, Dkt 625 D Del June 10, 2008 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1003 Exhibit: Ex 1003 Desai et al, US Patent No 5,439,686

Document IPR2017-01100, No. 1003-2 Exhibit - Ex 1003 Desai et al, US Patent No 5,439,686 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze
<< 1 2 3 4 5 6 7 8 9 10 >>